Cambridge Therapeutic Technologies
Teaneck, US
Biotech
Founders & leadership
JA
John A. KleinExecutive Officer, Director
MA
Marc A. WassermanDirector
BA
Barry A. PosnerExecutive Officer, Director
JA
Joseph A. DosSantosExecutive Officer
Reported raises · per SEC filings
Form D private placements$6MraisedOct 2016 · 14 investors · Pharmaceuticals
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.